Gilead Sciences SVP Erin Burkhart Reports Routine RSU Vesting & Tax Withholding
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
=== INSIDER TRANSACTION REPORT ===
Company: GILEAD SCIENCES, INC. (GILD)
Insider: Burkhart Erin
Title: SVP, Controllership
Date: 2026-09-22
Type: Tax Withholding (Code F)
Shares: 768 withheld @ $152.67 ($117,250.56)
Net Acquired: 1,455 shares (from 2,223 RSU vest)
Ending Shares: 1,455
Significance: Low (Routine vesting event)
Comprehensive Analysis
Executive Summary
On September 22, 2026, Erin Burkhart, Senior Vice President of Controllership at Gilead Sciences, Inc. ($GILD), settled 2,223 Restricted Stock Units (RSUs) into common stock. To satisfy statutory tax withholding requirements upon vesting, 768 shares were withheld at a market price of $152.67 per share, totaling $117,250.56. Following these transactions, Burkhart directly holds 1,455 shares of common stock and retains 9,022 unvested RSUs.
Transaction Breakdown
- RSU Conversion (Code M): 2,223 RSUs converted to common stock on a 1:1 basis at $0.00.
- Tax Withholding (Code F): 768 common shares surrendered at $152.67 per share to cover tax obligations, resulting in a net addition of 1,455 directly owned common shares.
- Derivative Holdings: 9,022 unvested RSUs remain subject to the company's 4-year vesting schedule.
Market Impact & Significance
This filing reflects routine equity compensation vesting and mandatory tax withholding rather than discretionary open-market trading. As such, the transaction carries low informational signal regarding executive sentiment on company performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.